Drug-induced liver toxicity and prevention by herbal antioxidants: An Overview

Frontiers in Physiology

Volumn 6, Issue JAN, 2016, Pages

  Singh, Divya ^a   Cho, William C ^b   Upadhyay, Ghanshyam ^a  

^a CITY COLLEGE OF NEW YORK   (United States)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Antioxidant; Hepatoprotection; Hepatotoxicity; Herbal medicine

Indexed keywords

AMIODARONE; AMOXICILLIN; ANTIOXIDANT; CELL NUCLEUS RECEPTOR; CHLORPROMAZINE; CIPROFLOXACIN; CURCUMIN; CYTOCHROME P450; DICLOFENAC; DRUG METABOLIZING ENZYME; ERYTHROMYCIN; GINKGO BILOBA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISONIAZID; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PYROGALLOL; RESVERATROL; RIFAMPICIN; SILYMARIN; TUBERCULOSTATIC AGENT; VALPROIC ACID;

ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; FATTY LIVER; HEPATITIS; HERBAL MEDICINE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; JAUNDICE; LIPID PEROXIDATION; LIVER FAILURE; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PHYTOCHEMISTRY; REVIEW; SCHIZOPHRENIA; SLEEP DISORDER; TOXIC HEPATITIS; TREATMENT DURATION; TUBERCULOSIS; XENOBIOTIC METABOLISM;

EID: 84962808952     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00363     Document Type: Review

References (242)

1. Aggarwal, B. B., and Shishioda, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421. doi: 10.1016/j.bcp.2006.02.009.
2. Ahmad, I., Shukla, S., Kumar, A., Singh, B. K., Kumar, V., Chauhan, A. K., et al. (2013). Biochemical and molecular mechanisms of N-acetyl cysteine and silymarin-mediated protection against maneb-and paraquat-induced hepatotoxicity in rats. Chem. Biol. Interact. 201, 9-18. doi: 10.1016/j.cbi.2012.10.027.
3. Ahmed, R. S., and Pawar, S. S. (1997). Effect of inducers on hepatic microsomal mixed function oxidase system of male rats during food restriction. Indian J. Exp. Biol. 35, 46-49.
4. Aithal, G. P. (2004). Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Expert Opin. Drug Saf. 3, 519-523. doi: 10.1517/14740338.3.6.519.
5. Aithal, G. P. (2011). Hepatotoxicity related to antirheumatic drugs. Nat. Rev. Rheumatol. 7, 139-150. doi: 10.1038/nrrheum.2010.214.
6. Akagawa, M., Shigemitsu, T., and Suyama, K. (2003). Production of hydrogen peroxide by polyphenol and polyphenol-rich beverages under quasi-physiological conditions. Biosci. Biotechnol. Biochem. 67, 2632-2640. doi: 10.1271/bbb.67.2632.
7. Aleksunes, L. M., Slitt, A. M., Cherrington, N. J., Thibodeau, M. S., Klaassen, C. D., and Manautou, J. E. (2005). Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride. Toxicol. Sci. 83, 44-52. doi: 10.1093/toxsci/kfi013.
8. Alexander, M. R., Louie, S. G., and Guernsey, B. G. (1982). Isoniazid associated hepatitis. Clin. Pharmacol. 1, 148-153.
9. Allen, S. J., Gan, Q., Matthews, R., and Johnson, P. A. (2003). Comparison of optimised isotherm models for basic dye adsorption by kudzu. Bioresour. Technol. 88, 143-152. doi: 10.1016/S0960-8524(02)00281-X.
10. Alonso, J. J., Osorio, J. M., Cabello, F. G., Osa, A. L., Leon, L., and Garcia, J. D. M. (1999). Atorvastatin induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Arch. Intern. Med. 159, 1811-1812. doi: 10.1001/archinte.159.15.1811-a.
11. Andrieu, S., Gillette, S., Amouyal, K., Nourhashemi, F., Reynish, E., Ousset, P. J., et al. (2003). Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. J. Gerontol. 58, 372-377. doi: 10.1093/gerona/58.4.m372.
12. Anundi, I., Lahteenmaki, T., Rundgren, M., Moldeus, P., and Lindros, K. O. (1993). Zonation of acetaminophen metabolism and cytochrome P450 2E1-mediated toxicity studies in isolated periportal and perivenous hepatocytes. Biochem. Pharmacol. 45, 1251-1259. doi: 10.1016/0006-2952(93)90277-4.
13. Arrese, M., and Accatino, L. (2002). From blood to bile: recent advances in hepatobiliary transport. Ann. Hepatol. 1, 64-71.
14. Atmaca, N., Atmaca, H. T., Kanici, A., and Anteplioglu, T. (2014). Protective effect of resveratrol on sodium fluoride-induced oxidative stress, hepatotoxicity and neurotoxicity in rats. Food Chem. Toxicol. 70, 191-197. doi: 10.1016/j.fct.2014.05.011.
15. Attri, S., Rana, S. V., Vaiphie, K., Katyal, R., Sodhi, C. P., Kanwar, S., et al. (2001). Protective effect of N-acetylcysteine in isoniazid induced hepatic injury in growing rats. Indian J. Exp. Biol. 39, 436-440.
16. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., et al. (2000). Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology 148, 187-197. doi: 10.1016/S0300-483X(00)00210-9.
17. Bahmani, M., Shirzad, H., Rafieian, S., and Rafieian-Kopaei, M. (2015). Silybum marianum: beyond hepatoprotection. J. Evid. Based Complementary Altern. Med. 20, 292-301. doi: 10.1177/2156587215571116.
18. Bakke, O. M., Manocchia, M., de Abajo, F., Kaitin, K. I., and Lasagna, L. (1995). Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective. Clin. Pharmacol. Ther. 58, 108-117. doi: 10.1016/0009-9236(95)90078-0.
19. Banks, A. T., Zimmerman, H. J., Ishak, K. G., and Harter, J. G. (1995). Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22, 820-827.
20. Bauer, M., and Bauer, I. (2002). Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxid. Redox. Signal. 4, 749-758. doi: 10.1089/152308602760598891.
21. Bell, L. N., and Chalasani, N. (2009). Epidemiology of idiosyncratic drug-induced liver injury. Semin. Liver Dis. 29:337. doi: 10.1055/s-0029-1240002.
22. Bellomo, G., and Orrenius, S. (1985). Altered thiol and calcium homeostasis in the oxidative hepatocellular injury. Hepatology 5, 876-882. doi: 10.1002/hep.1840050529.
23. Ben-Amotz, A., Yatziv, S., Sela, M., Greenberg, S., Rachmilevich, B., Shwarzman, M., et al. (1998). Effect of natural beta-carotene supplementation in children exposed to radiation from the Chernobyl accident. Radiat. Environ. Biophys. 37, 87-193. doi: 10.1007/s004110050116.
24. Biour, M., Ben Salem, C., Chazouillères, O., Grangé, J. D., Serfaty, L., and Poupon, R. (2004). Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs. Gastroenterol. Clin. Biol. 28, 720-759. doi: 10.1016/S0399-8320(04)95062-2.
25. Björnsson, E. (2009). The natural history of drug-induced liver injury. Semin. Liver Dis. 29, 357-363. doi: 10.1055/s-0029-1240004.
26. Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., Olafsson, S., et al. (2013). Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 144:1419. doi: 10.1053/j.gastro.2013.02.006.
27. Blazer, D. G., and Wu, L. T. (2009). Nonprescription use of pain relievers by middle-aged and elderly community-living adults: national survey on drug use and health. J. Am. Geriatr. Soc. 57, 1252-1257. doi: 10.1111/j.1532-5415.2009.02306.x.
28. Boelsterli, U. A., Ho, H. K., Zhou, S., and Leow, K. Y. (2006). Bioactivation and hepatotoxicity of nitroaromatic drugs. Curr. Drug Metab. 7, 715-727. doi: 10.2174/138920006778520606.
29. Bol'shakova, I. V., Lozovskaia, E. L., and Sapezhinskii, I. I. (1997). Antioxidant properties of a series of extracts from medicinal plants. Biofizika 42, 480-483.
30. Boyland, E., and Nery, R. (1969). Mercapturic acid formation during the metabolism of arecoline and arecaidine in the rat. Biochem. J. 113, 123-130. doi: 10.1042/bj1130123.
31. Cao, G., Sofic, E., and Prior, R. L. (1997). Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 22, 749-760. doi: 10.1016/S0891-5849(96)00351-6.
32. Chalasani, N., Fontana, R. J., Bonkovsky, H. L., Watkins, P. B., Davern, T., Serrano, J., et al. (2008). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135:1924. doi: 10.1053/j.gastro.2008.09.011.
33. Chang, T. K., Chen, J., and Lee, W. B. (2001). Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 299, 874-882.
34. Chearwae, W., Anuchapreeda, S., Nandigama, K., Ambudkar, S. V., and Limtrakul, P. (2004). Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem. Pharmacol. 68, 2043-2052. doi: 10.1016/j.bcp.2004.07.009.
35. Chen, J., Zhang, W., Lu, T., Li, J., Zheng, Y., and Kong, L. (2006). Morphological and genetic characterization of a cultivated Cordyceps sinensis fungus and its polysaccharide component possessing antioxidant property in H22 tumor-bearing mice. Life Sci. 78, 2742-2748. doi: 10.1016/j.lfs.2005.10.047.
36. Chen, J. W., Chen, Y. H., Lin, F. Y., Chen, Y. L., and Lin, S. J. (2003). Ginkgo biloba extract inhibits tumor necrosis factor-(alpha)-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23, 1559-1566. doi: 10.1161/01.ATV.0000089012.73180.63.
37. Cheng, X., Maher, J., Dieter, M. Z., and Klaassen, C. D. (2005). Regulation of mouse organic anion-transporting polypeptides (oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways. Drug Metab. Dispos. 33, 1276-1282. doi: 10.1124/dmd.105.003988.
38. Chun, Y. J., Ryu, S. Y., Jeong, T. C., and Kim, M. Y. (2001). Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin. Drug Metab. Dispos. 29, 389-393.
39. Coleman, J. D., Prabhu, K. S., Thompson, J. T., Reddy, P. S., Peters, J. M., Peterson, B. R., et al. (2007). The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Free Radic. Biol. Med. 42, 1155-1164. doi: 10.1016/j.freeradbiomed.2007.01.003.
40. Contreras, A. M., Monteón, F. J., Flores, M. R., Mendoza-Sánchez, F., and Ruiz, I. (2007). Drug-related hepatotoxicity in a renal transplant recipient with long-term survival and hepatitis C. Ann. Hepatol. 6, 70-73.
41. Dahm, L. J., and Jones, D. P. (1996). "Mechanisms of chemically induced liver disease, " in Hepatology: A Textbook of Liver Disease, 3rd Edn., eds D. Zakin and T. D. Boyer (Philadelphia: WB Saunders), 875-890.
42. Dalaklioglu, S., Genc, G. E., Aksoy, N. H., Akcit, F., and Gumuslu, S. (2013). Resveratrol ameliorates methotrexate-induced hepatotoxicity in rats via inhibition of lipid peroxidation. Hum. Exp. Toxicol. 32, 662-671. doi: 10.1177/0960327112468178.
43. DeFeudis, F. V., Papadopoulos, V., and Drieu, K. (2003). Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam. Clin. Pharmacol. 17, 405-417. doi: 10.1046/j.1472-8206.2003.00156.x.
44. De Groot, H., and Noll, T. (1983). Halothane hepatotoxicity: relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage. Hepatology 3, 601-606. doi: 10.1002/hep.1840030421.
45. De la Puerta, R., Martinez, E., Bravo, L., and Ahumada, M. C. (1996). Effect of silymarin on different acute inflammation models and on leukocyte migration. J. Pharm. Pharmacol. 48, 968-970. doi: 10.1111/j.2042-7158.1996.tb06014.x.
46. Deng, Y., Bi, H. C., Zhao, L. Z., He, F., Liu, Y. Q., Yu, J. J., et al. (2008). Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats. Xenobiotica 38, 465-481. doi: 10.1080/00498250701883233.
47. Denison, M. S., and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334. doi: 10.1146/annurev.pharmtox.43.100901.135828.
48. DerMarderosian, A. (ed.). (2001). The Review of Natural Products, 1st Edn. St. Louis: Facts and Comparisons.
49. De Smet, P. A. (2002). Herbal remedies. New Eng. J. Med. 347, 2046-2056. doi: 10.1056/NEJMra020398.
50. Diamond, B. J., Shiflett, S. C., Feiwel, N., Matheis, R. J., Noskin, O., Richards, J. A., et al. (2000). Ginkgo biloba extract: mechanisms and clinical indications. Arch. Phys. Med. Rehabil. 81, 668-678. doi: 10.1016/s0003-9993(00)90052-2.
51. Duarte, A. (1995). Health Alternatives. Morton Grove, IL: Megasystems.
52. Duvoix, A., Blasius, R., Delhalle, S., Schenkenburger, M., Morceau, F., Henry, E., et al. (2005). Chemopreventive and therapeutic eVects of curcumin. Cancer Lett. 223, 181-190. doi: 10.1016/j.canlet.2004.09.041.
53. Fahey, A. J., Adrian Robins, R., and Constantinescu, C. S. (2007). Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells. J. Cell Mol. Med. 11, 1129-1137. doi: 10.1111/j.1582-4934.2007.00089.x.
54. Farombi, E. O., Akinloye, O., Akinmoladun, C. O., and Emerole, G. O. (1999). Hepatic drug metabolizing enzyme induction and serum triacylglycerol elevation in rats treated with chlordiazepoxide, griseofulvin, rifampicin and phenytoin. Clin. Chim. Acta 289, 1-10. doi: 10.1016/S0009-8981(99)00143-6.
55. Farombi, E. O., and Surh, Y. J. (2006). Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J. Biochem. Mol. Biol. 39, 479-491. doi: 10.5483/BMBRep.2006.39.5.479.
56. Flora, K., Hahn, M., Rosen, H., and Brenner, K. (1996). Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol. 93, 139-143. doi: 10.1111/j.1572-0241.1998.00139.x.
57. Frémont, L. (2000). Biological effects of resveratrol. Life Sci. 66, 663-673. doi: 10.1016/S0024-3205(99)00410-5.
58. Fuchs, E. C., Weyhenmeyer, R., and Weiner, O. H. (1997). Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts. Arzneimittelforschung 47, 1383-1387.
59. García, J. J., Reiter, R. J., Guerrero, J. M., Escames, G., Yu, B. P., Oh, C. S., et al. (1997). Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 408, 297-300. doi: 10.1016/S0014-5793(97)00447-X.
60. García-Niño, W. R., and Pedraza-Chaverrí, J. (2014). Protective effect of curcumin against heavy metals-induced liver damage. Food Chem. Toxicol. 69, 182-201. doi: 10.1016/j.fct.2014.04.016.
61. Gautam, S. C., Gao, X., and Dulchavsky, S. (2007). Immunomodulation by curcumin. Adv. Exp. Med. Biol. 595, 321-341. doi: 10.1007/978-0-387-46401-5_14.
62. Geahlen, R. L., and McLaughlin, J. L. (1989). Isolation of piceatannol as the antileukemic principle from the seeds of euphorbia lagascae. Biochem. Biophys. Res. Commun. 165, 241-245. doi: 10.1016/0006-291X(89)91060-7.
63. Geier, A., Kim, S. K., Gerloff, T., Dietrich, C. G., Lammert, F., Karpen, S. J., et al. (2002). Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. J. Hepatol. 37, 198-205. doi: 10.1016/S0168-8278(02)00108-3.
64. Gescher, A. J., and Steward, W. P. (2003). Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol. Biomark 12, 953-957.
65. Ghanem, C. I., Gómez, P. C., Arana, M. C., Perassolo, M., Ruiz, M. L., Villanueva, S. S., et al. (2004). Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Biochem. Pharmacol. 68, 791-798. doi: 10.1016/j.bcp.2004.05.014.
66. Gruenwald, J., Brendler, T., and Jaenicke, C. (eds.). (2000). PDR for Herbal Medicine, 2nd Edn. Montvale, NJ: Medical Economics.
67. Guengerich, F. P. (1999). Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu. Rev. Pharmacol. Toxicol. 39, 1-17. doi: 10.1146/annurev.pharmtox.39.1.1.
68. Guerra, M. C., Speroni, E., Broccoli, M., Cangini, M., Pasini, P., Mingett, A., et al. (2000). Comparison between Chinese medical herb Peuraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalased drug metabolism. Life Sci. 67, 2997-3006. doi: 10.1016/S0024-3205(00)00885-7.
69. Gupta, Y. K., Sharma, M., and Chaudhary, G. (2002). Pyrogallol-induced hepatotoxicity in rats: a model to evaluate antioxidant hepatoprotective agents. Methods Find. Exp. Clin. Pharmacol. 24, 497-500. doi: 10.1358/mf.2002.24.8.705070.
70. Gupta, Y. K., Sharma, M., Chaudhary, G., and Katiyar, C. K. (2004). Hepatoprotective effect of New Livfit, a polyherbal formulation, is mediated through its free radical scavenging activity. Phytother. Res. 18, 362-364. doi: 10.1002/ptr.1272.
71. Gurocak, S., Karabulut, E., Karadag, N., Ozgor, D., Ozkeles, N., and Karabulut, A. B. (2013). Preventive effects of resveratrol against azoxymethane induced damage in rat liver. Asian Pac. J. Cancer Prev. 14, 2367-2370. doi: 10.7314/APJCP.2013.14.4.2367.
72. Guven, A., and Gulmez, M. (2003). The effect of kefir on the activities of GSH-Px, G. S. T., CAT, GSH and LPO levels in carbon tetrachloride-induced mice tissues. J. Vet. Med. B 50, 412-416. doi: 10.1046/j.1439-0450.2003.00693.x.
73. Habig, W. H., Pabst, M. J., and Jakaby, W. B. (1974). Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130-7139.
74. Halvorsen, B. L., Holte, K., Myhrstad, M. C., Barikmo, I., Hvattum, E., Remberg, S. F., et al. (2002). A systematic screening of total antioxidants in dietary plants. J. Nutr. 132, 461-471.
75. Hayakawa, F., Kimura, T., Maeda, T., Fujita, M., Sohmiya, H., Fujii, M., et al. (1997). DNA cleavage reaction and linoleic acid peroxidation induced by tea catechins in the presence of cupric ion. Biochim. Biophys. Acta 1336, 123-131. doi: 10.1016/S0304-4165(97)00019-6.
76. Hayes, J. D., and McMahon, M. (2001). Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 174, 103-113. doi: 10.1016/S0304-3835(01)00695-4.
77. Heijne, W. H., Slitt, A. L., van Bladeren, P. J., Groten, J. P., Klaassen, C. D., Stierum, R. H., et al. (2004). Bromobenzene-induced hepatotoxicity at the transcriptome level. Toxicol. Sci. 79, 411-422. doi: 10.1093/toxsci/kfh128.
78. Hemmeter, U., Annen, B., Bischof, R., Brüderlin, U., Hatzinger, M., Rose, U., et al. (2001). Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine. Pharmacopsychiatry 34, 50-59. doi: 10.1055/s-2001-15182.
79. Hinson, J. A., Reid, A. B., McCullough, S. S., and James, L. P. (2004). Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab. Rev. 36, 805-822. doi: 10.1081/DMR-200033494.
80. Holt, M., and Ju, C. (2010). Drug-induced liver injury. Handb. Exp. Pharmacol. 196, 3-27. doi: 10.1007/978-3-642-00663-0_1.
81. Hong, X. Z., Li, L. D., and Wu, L. M. (2007). Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease. Clin. Exp. Pharmacol. Physiol. 34, 27-35. doi: 10.1111/j.1440-1681.2007.04547.x.
82. Honkakoski, P., and Negishi, M. (2000). Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347(Pt 2), 321-337. doi: 10.1042/bj3470321.
83. Horsmans, Y., Desager, J. P., and Harvengt, C. (1990). Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor). Pharmacol. Toxicol. 67, 336-339. doi: 10.1111/j.1600-0773.1990.tb00840.x.
84. Huang, Y. S., Chern, H. D., Su, W. J., Wu, J. C., Lai, S. L., Yang, S. Y., et al. (2002). Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 35, 883-889. doi: 10.1053/jhep.2002.32102.
85. Huang, Y. S., Chern, H. D., Su, W. J., Wu, J. C., Chang, S. C., Chiang, C. H., et al. (2003). Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology 37, 924-930. doi: 10.1053/jhep.2003.50144.
86. Hwang, J. M., Wang, C. J., Chou, F. P., Tseng, T. H., Hsieh, Y. S., Hsu, J. D., et al. (2005). Protective effect of baicalin on tert-butyl hydroperoxide-induced rat hepatotoxicity. Arch. Toxicol. 79, 102-109. doi: 10.1007/s00204-004-0588-6.
87. Ignatowicz, E., and Baer-Dubowska, W. (2001). Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol. J. Pharmacol. 53, 557-569.
88. Immenschuh, S., and Ramadori, G. (2000). Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem. Pharmacol. 60, 1121-1128. doi: 10.1016/S0006-2952(00)00443-3.
89. Jacob, A., Wu, R., Zhou, M., and Wang, P. (2007). Mechanism of the anti-inflammatory effect of curcumin: PPAR-gamma Activation. PPAR Res. 2007:89369. doi: 10.1155/2007/89369.
90. Jacobson, T. A. (2006). The safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered? Mayo Clin. Proc. 81, 1225-1231. doi: 10.4065/81.9.1225.
91. Jacqz-Aigrain, E., and Anderson, B. J. (2006). Pain control: non-steroidal anti-inflammatory agents. Semin. Fetal Neonatal Med. 11, 251-259. doi: 10.1016/j.siny.2006.02.009.
92. Jaeschke, H., Gores, G. J., Cederbaum, A. I., Hinson, J. A., Pessayre, D., and Lemasters, J. J. (2002). Mechanisms of hepatotoxicity. Toxicol. Sci. 65, 166-176. doi: 10.1093/toxsci/65.2.166.
93. Jaggy, H., and Koch, E. (1997). Chemistry and biology of alkylphenols from Ginkgo biloba L. Pharmazie. 52, 735-738.
94. Jaiswal, A. K. (2000). Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic. Biol. Med. 29, 254-262. doi: 10.1016/S0891-5849(00)00306-3.
95. Joe, B., Vijaykumar, M., and Lokesh, B. R. (2004). Biological properties of Curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 44, 97-111. doi: 10.1080/10408690490424702.
96. Johnson, D. R., and Klaassen, C. D. (2002). Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. Toxico. Sci. 69, 317-321. doi: 10.1093/toxsci/67.2.182.
97. Joyeux, M., Rolland, A., Fleurentin, J., Mortier, F., and Dorfman, P. (1990). Tertbutylhydroperoxide-induced injury in isolated rat hepatocytes: a model for studying antihepatotoxic crude drugs. Planta Med. 56, 171-174. doi: 10.1055/s-2006-960918.
98. Kaplowitz, N. (2001). Drug-induced liver disorders: implications for drug development and regulation. Drug Saf. 24, 483-490. doi: 10.2165/00002018-200124070-00001.
99. Karthikeyan, S. (2005). Isoniazid and rifampicin treatment on phospholipids and their subfractions in liver tissue of rabbits. Drug Chem. Toxicol. 28, 273-280. doi: 10.1081/DCT-200064463.
100. Kim, D. S., Kim, D. S., and Oppel, M. N. (2002). Shogaols from Zingiber officinale protect IMR32 human neuroblastoma and normal human umbilical vein endothelial cells from beta-amyloid (25-35) insult. Planta Med. 68, 375-376. doi: 10.1055/s-2002-26757.
101. King, J. C., and Cousins, R. J. (2006). "Zinc, " in Modern Nutrition in Health and Disease, 10th Edn, eds M. E. Shils, M. Shike, A. C. Ross, B. Caballero, and R. J. Cousins (Philadelphia, PA: Lipponcott Williams and Wilkins), 271-285.
102. Kissler, H. J., Hauffen, J., Hennig, R., Gepp, H., and Schwille, P. O. (2005). Glucose and lipid metabolism after liver transplantation in inbred rats: consequences of hepatic denervation. Metab. Clin. Exp. 54, 881-890. doi: 10.1016/j.metabol.2005.01.036.
103. Kliewer, S. A. (2003). The nuclear pregnane X receptor regulates xenobiotic detoxification. J. Nutr. 133, 2444S-2447S.
104. Kobayashi, K., Urashima, K., Shimada, N., and Chiba, K. (2002). Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochem. Pharmacol. 63, 889-896. doi: 10.1016/S0006-2952(01)00843-7.
105. Kohno, H., Tanaka, T., Kawabata, K., Hirose, Y., Sugie, S., Tsuda, H., and Mori, H. (2002). Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male f344 rats. Int. J. Cancer 101, 461-468. doi: 10.1002/ijc.10625.
106. Koster, J. F., and Slee, R. G. (1980). Lipid peroxidation of rat liver microsomes. Biochim. Biophys. Acta 620, 489-499. doi: 10.1016/0005-2760(80)90141-1.
107. Krieglstein, J., Ausmeier, F., Elabhar, H., Lippert, K., Welsch, M., Rupalla, K., et al. (1995). Neuroprotective effects of Ginkgo biloba constituents. Eur. J. Pharm. Sci. 3, 39-48. doi: 10.1016/0928-0987(94)00073-9.
108. Kvasnicka, F., Bíba, B., Sevcík, R., Voldrich, M., and Krátká, J. (2003). Analysis of the active components of silymarin. J. Chromatogr. A. 990, 239-245. doi: 10.1016/S0021-9673(02)01971-4.
109. Larrey, D. (2000). Drug-induced liver diseases. J. Hepatol. 32(Suppl. 1), 77-88. doi: 10.1016/S0168-8278(00)80417-1.
110. Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., et al. (2005). Acute liver failure study group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42, 1364-1372. doi: 10.1002/hep.20948.
111. Latruffe, N., Delmas, D., Jannin, B., Cherkaoui-Malki, M., Passilly-Degrace, P., and Berlot, J. P. (2002). Molecular analysis on the chemopreventive properties of resveratrol a plant polyphenol microcomponent. Int. J. Mol. Med. 10, 755-760. doi: 10.3892/ijmm.10.6.755.
112. Lee, H. I., McGregor, R. A., Choi, M. S., Seo, K. I., Jung, U. J., Yeo, J., et al. (2013). Low doses of curcumin protect alcohol-induced liver damage by modulation of the alcohol metabolic pathway, CYP2E1 and AMPK. Life Sci. 93, 693-699. doi: 10.1016/j.lfs.2013.09.014.
113. Lee, J. S., and Surh, Y. J. (2005). Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 224, 171-184. doi: 10.1016/j.canlet.2004.09.042.
114. Lee, W. M. (2003). Drug-induced hepatotoxicity. N. Engl. J. Med. 349, 474-485. doi: 10.1056/NEJMra021844.
115. Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., and Kliewer, S. A. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016-1023. doi: 10.1172/JCI3703.
116. Lewis, J. H., and Zimmerman, H. J. (1989). Drug-induced liver disease. Med. Clin. North. Am. 73, 775-792.
117. Lichtblau, D., Berger, J. M., and Nakanishi, K. (2002). Efficient extraction of ginkgolides and bilobalide from Ginkgo biloba leaves. J. Nat. Prod. 65, 1501-1504. doi: 10.1021/np0201974.
118. Lin, T. H., Ng, L. T., Yen, F. L., and Lin, C. C. (2007). Hepatoprotective effects of Chai-Hu-Ching-Kan-Tang on acetaminophen-induced acute liver injury in rats. Am. J. Chin. Med. 35, 69-79. doi: 10.1142/S0192415X07004631.
119. Liu, C. T., Chuang, P. T., Wu, C. Y., Weng, Y. M., Chen, W., and Tseng, C. Y. (2006). Antioxidative and in vitro hepatoprotective activity of Bupleurum kaoi leaf infusion. Phytother. Res. 20, 1003-1008. doi: 10.1002/ptr.1946.
120. Lu, H., and Liu, G. T. (1992). Anti-oxidant activity of dibenzocyclooctene lignans isolated from Schisandraceae. Planta Med. 58, 311-313. doi: 10.1055/s-2006-961473.
121. Madrigal-Santillán, E., Madrigal-Bujaidar, E., Álvarez-González, I., Sumaya-Martínez, M. T., Gutiérrez-Salinas, J., Bautista, M., et al. (2014). Review of natural products with hepatoprotective effects. World J. Gastroenterol. 20, 14787-14804. doi: 10.3748/wjg.v20.i40.14787.
122. Madrigal-Santillán, E., Madrigal-Bujaidar, E., Cruz-Jaime, S., Valadez-Vega, M. C., Sumaya-Martínez, M. T., Pérez-ávila, K. G., et al. (2013). "The chemoprevention of chronic degenerative disease through dietary antioxidants: progress, promise and evidences, " in Oxidative Stress and Chronic Degenerative Diseases-a Role for Antioxidants, ed J. A. Morales-González (Rijeka: Croatia InTech), 155-185.
123. Mahady, G. B. (2002). Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature. J. Cardiovas. Nurs. 16, 21-32. doi: 10.1097/00005082-200207000-00004.
124. Maheshwari, R. K., Singh, A. K., Gaddipati, J., and Srimal, R. C. (2006). Multiple biological activities of curcumin: a short review. Life Sci. 78, 2081-2087. doi: 10.1016/j.lfs.2005.12.007.
125. Mangelsdorf, D. J., and Evans, R. M. (1995). The RXR heterodimers and orphan receptors. Cell 83, 841-850. doi: 10.1016/0092-8674(95)90200-7.
126. Markham, K. R., and Mitchell, K. A. (2003). The mis-identification of the major antioxidant flavonoids in young barley (Hordeum vulgare) leaves. Z. Naturforsch. C 58, 53-56. doi: 10.1515/znc-2003-1-209.
127. Masson, M. J., Peterson, R. A., Chung, C. J., Graf, M. L., Carpenter, L. D., Ambroso, J. L., et al. (2007). Lymphocyte loss and immunosuppression following acetaminophen-induced hepatotoxicity in mice as a potential mechanism of tolerance. Chem. Res. Toxicol. 20, 20-26. doi: 10.1021/tx060190c.
128. Masubuchi, N., Makino, C., and Murayama, N. (2007). Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans. Chem. Res. Toxicol. 20, 455-464. doi: 10.1021/tx060234h.
129. McGill, M. R., Sharpe, M. R., Williams, C. D., Taha, M., Curry, S. C., and Jaeschke, H. (2012). The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J. Clin. Invest. 122, 1574-1583. doi: 10.1172/JCI59755.
130. McKenna, D. J., Jones, K., and Hughes, K. (2001). Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern. Ther. Health Med. 7, 70-86.
131. Miguez, M. P., Anundi, I., Sainz-Pardo, L. A., and Lindros, K. O. (1994). Comparative study of the hepatoprotective effect of silymarin and silybin on isolated rat hepatocytes. Toxicol. In Vitro 8, 581-583. doi: 10.1016/0887-2333(94)90021-3.
132. Mikstacka, R., Gnojkowski, J., and Baer-Dubowska, W. (2002). Effect of natural phenols on the catalytic activity of cytochrome P4502E1. Acta Biochim. Pol. 49, 917-925.
133. Mindie, H. N., and Gabriel, G. (2002). Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriors? Am. J. Gastroenterol. 97, 1092-1093. doi: 10.1111/j.1572-0241.2002.05700.x.
134. Mira, L., Silva, M., and Manso, C. F. (1994). Scavenging of reactive oxygen species by silibinin hemisuccinate. Biochem. Pharmacol. 48, 753-759. doi: 10.1016/0006-2952(94)90053-1.
135. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. (1973). Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187, 185-194.
136. Mitchell, J. R., Thorgeirsson, U. P., Black, M., Timbrell, J. A., Snodgrass, W. R., Potter, W. Z., et al. (1975). Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites. Clin. Pharmacol. Ther. 18, 70-79.
137. Mitchell, S. J., and Hilmer, S. N. (2010). Drug-induced liver injury in older adults. Ther. Adv. Drug Saf. 1, 65-77. doi: 10.1177/2042098610386281.
138. Mitka, M. (2014). FDA asks physicians to stop prescribing high-dose acetaminophen products. JAMA 311, 563. doi: 10.1001/jama.2014.716.
139. Mochizuki, M., Yamazaki, S., Kano, K., and Ikeda, T. (2002). Kinetic analysis and mechanistic aspects of autooxidation of catechins. Biochim. Biophys. Acta 1569, 35-44. doi: 10.1016/S0304-4165(01)00230-6.
140. Mohapatra, R., Tran, M., Gore, J. M., and Spencer, F. A. (2005). A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era. Am. Heart J. 150, 19-26. doi: 10.1016/j.ahj.2005.02.012.
141. Moon, Y. J., Wang, X., and Morris, M. E. (2006). Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 20, 187-210. doi: 10.1016/j.tiv.2005.06.048.
142. Motohashi, H., and Yamamoto, M. (2004). Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549-557. doi: 10.1016/j.molmed.2004.09.003.
143. Muriel, P., and Mourelle, M. (1990). Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J. Appl. Toxicol. 10, 275-279. doi: 10.1002/jat.2550100408.
144. Nasri, H., Sahinfard, N., Rafieian, M., Rafieian, S., Shirzad, M., and Rafieian-Kopaei, M. (2013). Effects of Allium sativum on liver enzymes and atherosclerotic risk factors. J. Herb. Med. Pharmacol. 2, 23-28.
145. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., et al. (1996). P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42. doi: 10.1097/00008571-199602000-00002.
146. Okada, K., Shoda, J., Kano, M., Suzuki, S., Ohtake, N., Yamamoto, M., et al. (2007). Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1450-G1463. doi: 10.1152/ajpgi.00302.2006.
147. Oken, B. S., Storzbach, D. M., and Kaye, J. A. (1998). The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch. Neurol. 55, 1409-1415. doi: 10.1001/archneur.55.11.1409.
148. Olaleye, M. T., and Rocha, B. T. (2008). Acetaminophen-induced liver damage in mice: effects of some medicinal plants on the oxidative defense system. Exp. Toxicol. Pathol. 59, 319-327. doi: 10.1016/j.etp.2007.10.003.
149. Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H., et al. (2002). Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med. 137, 947-954. doi: 10.7326/0003-4819-137-12-200212170-00007.
150. Pal, R., Vaiphei, K., Sikander, A., Singh, K., and Rana, S. V. (2006). Effect of garlic on isoniazid and rifampicin-induced hepatic injury in rats. World J. Gastroenterol. 12, 636-639.
151. Pan, M. H., Huang, T. M., and Lin, J. K. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabol. Dispos. 27, 486-494.
152. Pandit, A., Sachdeva, T., and Bafna, P. (2012). Drug-induced hepatotoxicity: a review. J. Appl. Pharm. Sci. 02, 233-243. doi: 10.7324/japs.2012.2541.
153. Park, B. K., Kitteringham, N. R., Maggs, J. L., Pirmohamed, M., and Williams, D. P. (2005). The role of metabolic activation in drug-induced hepatotoxicity. Ann. Rev. Pharmacol. Toxicol. 45, 177-202. doi: 10.1146/annurev.pharmtox.45.120403.100058.
154. Plummer, S. M., Holloway, K. A., Manson, M. M., Munks, R. J. L., Kaptein, A., Farrow, S., et al. (1999). Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappa B activation via the NIK/IKK signalling complex. Oncogene 18, 6013-6020. doi: 10.1038/sj.onc.1202980.
155. Polyak, S. J., Morishima, C., Shuhart, M. C., Wang, C. C., Liu, Y., and Lee, D. Y. (2007). Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology 132, 1925-1936. doi: 10.1053/j.gastro.2007.02.038.
156. Ponto, L. L., and Schultz, S. K. (2003). Ginkgo biloba extract: review of CNS effects. Ann. Clin. Psychiatry 15, 109-119. doi: 10.3109/10401230309085676.
157. Porceddu, M., Buron, N., Roussel, C., Labbe, G., Fromenty, B., and Borgne-Sanchez, A. (2012). Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicol. Sci. 129, 332-345. doi: 10.1093/toxsci/KFS197.
158. Potter, G. A., Patterson, L. H., Wanogho, E., Perry, P. J., Butler, P. C., Ijaz, T., et al. (2002). The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 86, 774-778. doi: 10.1038/sj.bjc.6600197.
159. Powell-Jackson, P. R., Tredger, J. M., Smith, H. W., and Williams, R. (1982). Effect of isoniazid administration on selected rat and mouse hepatic microsomal mixed-function oxidase and in vitro (C14) acetylhydrazine-derived covalent binding. Biochem. Pharmacol. 31, 4031-4034. doi: 10.1016/0006-2952(82)90651-7.
160. Racknagel, R. O., Glende, E. J. R., Dolak, J. A., and Waller, R. I. (1989). Mechanisms of carbon tetrachloride toxicity. Pharmacol. Ther. 43, 130-154. doi: 10.1016/0163-7258(89)90050-8.
161. Ramachandran, P. C. (1980). Chemotherapy of tubercular meningitis with isoniazid plus rifampicin. Interim findings in a trial in children. Ind. J. Tuberc. 27, 54-56.
162. Rana, S. V., Attri, S., Vaiphei, K., Pal, R., Attri, A., and Singh, K. (2006). Role of N-acetylcysteine in rifampicin-induced hepatic injury of young rats. World J. Gastroenterol. 12, 287-291. doi: 10.3748/wjg.v12.i2.287.
163. Raucy, J. L., Lasker, J. M., Lieber, C. S., and Black, M. (1989). Acetaminophen ctivation by human liver cytochromes P450IIE1 and P450IA2. Arch. Biochem. Biophys. 271, 270-283. doi: 10.1016/0003-9861(89)90278-6.
164. Regev-Shoshani, G., Shoseyov, O., and Kerem, Z. (2004). Influence of lipophilicity on the interactions of hydroxy stilbenes with cytochrome P450 3A4. Biochem. Biophys. Res. Commun. 323, 668-673. doi: 10.1016/j.bbrc.2004.08.141.
165. Reid, A. B., Kurten, R. C., McCullough, S. S., Brock, R. W., and Hinson, J. A. (2005). Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J. Pharmacol. Exp. Ther. 312, 509-516. doi: 10.1124/jpet.104.075945.
166. Rendic, S. (2002). Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabol. Rev. 34, 83-448. doi: 10.1081/DMR-120001392.
167. Rezvani, A. H., Overstreet, D. H., Perfumi, M., and Massi, M. (2003). Plant derivatives in the treatment of alcohol dependency. Pharmacol. Biochem. Behav. 75, 593-606. doi: 10.1016/S0091-3057(03)00124-2.
168. Ross, D. (1988). Glutathione, free radicals and chemotherapeutic agents. Pharmacol. Ther. 37, 231-249. doi: 10.1016/0163-7258(88)90027-7.
169. Saito, C., Lemasters, J. J., and Jaeschke, H. (2010). c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 246, 8-17. doi: 10.1016/j.taap.2010.04.015.
170. Sandur, S. K., Pandey, M. K., Sung, B., Ahn, K. S., Murakami, A., Sethi, G., et al. (2007). Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28, 1765-1773. doi: 10.1093/carcin/bgm123.
171. Sankar, P., Gopal Telang, A., Kalaivanan, R., Karunakaran, V., Manikam, K., and Sarkar, S. N. (2015). Effects of nanoparticle-encapsulated curcumin on arsenic-induced liver toxicity in rats. Environ. Toxicol. 30, 628-637. doi: 10.1002/tox.21940.
172. Santhosh, S., Sini, T. K., Anandan, R., and Mathew, P. T. (2006). Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats. Toxicology 219, 53-59. doi: 10.1016/j.tox.2005.11.001.
173. Saraswathy, S. D., and Shyamala Devi, C. S. (2001). Modulating effect of Liv.100, an ayurvedic formulation on antituberculosis drug-induced alterations in rat liver microsomes. Phytother. Res. 15, 501-505. doi: 10.1002/ptr.770.
174. Sass, G., Soares, M. C., Yamashita, K., Seyfried, S., Zimmermann, W. H., Eschenhagen, T., et al. (2003). Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology 38, 909-918. doi: 10.1002/hep.1840380417.
175. Saukkonen, J. J., Cohn, D. L., Jasmer, R. M., Schenker, S., Jereb, J. A., Nolan, C. M., et al. (2006). ATS (American Thoracic Society) hepatotoxicity of antituberculosis therapy subcommittee. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am. J. Respir. Crit. Care Med. 174, 935-952. doi: 10.1164/rccm.200510-1666ST.
176. Scambia, G., De Vincenzo, R., Ranelletti, F. O., Panici, P. B., Ferrandina, G., D'Agostino, G., et al. (1996). Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin. Eur. J. Cancer 32A, 877-882. doi: 10.1016/0959-8049(96)00011-1.
177. Schneider, R., Welt, K., Aust, W., Löster, H., and Fitzl, G. (2008). Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: I. cardiomyocytes. Histol. Histopathol. 23, 807-817.
178. Shah, R. R. (1999). Drug-induced hepatotoxicity: pharmacokinetic perspectives and strategies for risk reduction. Adv. Drug React. Toxicol. Rev. 18, 181-233.
179. Shapiro, M. A., and Lewis, J. H. (2007). Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin. Liver Dis. 11, 477. doi: 10.1016/j.cld.2007.06.003.
180. Sheu, S. Y., Lai, C. H., and Chiang, H. C. (1998). Inhibition of xanthine oxidase by purpurogallin and silymarin group. Anticancer Res. 18, 263-268.
181. Shimizu, I. (2001). Antifibrogenic therapies in chronic HCV infection. Curr. Drug Targets Infect. Disord. 1, 227-240. doi: 10.2174/1568005014606053.
182. Singh, V., Ahmad, S., and Rao, G. S. (1994). Prooxident antioxident properties of iron-hydroquinone and iron-1, 2, 4-benzenetriol complex. Implications for benzene toxicity. Toxicology 89, 25-33. doi: 10.1016/0300-483X(94)90130-9.
183. Sinha, B. K. (1987). Activation of hydrazine derivatives of free radicals in the per fused rat liver: a spin trapping study. Biochim. Biophys. Acta 924, 261-269. doi: 10.1016/0304-4165(87)90021-3.
184. Snawder, J. E., Roe, A. L., Benson, R. W., and Roberts, D. W. (1994). Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity. Biochem. Biophys. Res. Commun. 203, 532-539. doi: 10.1006/bbrc.1994.2215.
185. Sodhi, C. P., Rana, S. F., Attari, S., Metha, S., Vaiphei, K., and Metha, S. K. (1998). Oxidative hepatic injury of isoniazid-rifampicin in young rats subjected to protein energy malnutrition. Drug Chem. Toxicol. 21, 305-317. doi: 10.3109/01480549809002207.
186. Sodhi, C. P., Rana, S. V., Mehta, S. K., Vaiphei, K., Attri, S., Thakur, S., et al. (1996). Study of oxidative stress in isoniazid-induced hepatic injury in young rats with and without protein-energy malnutrition. J. Biochem. Toxicol. 11, 139-146.
187. Soliman, M. M., Abdo Nassan, M., and Ismail, T. A. (2014). Immunohistochemical and molecular study on the protective effect of curcumin against hepatictoxicity induced by paracetamol in wistar rats. BMC Complement. Altern. Med. 29, 14:457. doi: 10.1186/1472-6882-14-457.
188. Soliman, M. M., Baiomy, A. A., and Yassin, M. H. (2015). Molecular and histopathological study on the ameliorative effects of curcumin against lead acetate-induced hepatotoxicity and nephrototoxicity in wistar rats. Biol. Trace Elem. Res. 167, 91-102. doi: 10.1007/s12011-015-0280-0.
189. Song, I. S., Lee, Y. M., Chung, S. J., and Shim, C. K. (2003). Multiple alterations of canalicular membrane transport activities in rats with CCl(4)-induced hepatic injury. Drug Metab. Dispos. 31, 482-490. doi: 10.1124/dmd.31.4.482.
190. Sonnenbichler, J., Scalera, F., Sonnenbichler, I., and Weyhenmeyer, R. (1999). Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. J. Pharmacol. Exp. Ther. 290, 1375-1383.
191. Sonnenbichler, J., and Zetl, I. (1986). Biochemical effects of the flavolignane silibinin on RNA, protein and DNA synthesis in rat liver. Progr. Clin. Biol. Res. 213, 319-331.
192. Sonoda, J., Rosenfeld, J. M., Xu, L., Evans, R. M., and Xie, W. (2003). A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. Curr. Drug Metab. 4, 59-72. doi: 10.2174/1389200033336739.
193. Srivastava, P., Prabhu, V. V., Yadav, N., Gogada, R., and Chandra, D. (2013). "Effect of dietary resveratrol in the treatment of cancer, " in Cancer Chemoprevention and Treatment by Diet Therapy, ed W. C. Cho (New York, NY: Springer), 1-22.
194. Staudinger, J. L., Ding, X., and Lichti, K. (2006). Pregnane X receptor and natural products: beyond drug-drug interactions. Expert Opin. Drug Metab. Toxicol. 2, 847-857. doi: 10.1517/17425255.2.6.847.
195. Steele, V. E., Kelloff, G. J., Wilkinson, B. P., and Arnold, J. T. (1990). Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res. 50, 2068-2074.
196. Stickel, F., and Shouval, D. (2015). Hepatotoxicity of herbal and dietary supplements: an update. Arch. Toxicol. 89, 851-865. doi: 10.1007/s00204-015-1471-3.
197. Surh, Y.-J. (1999). Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428, 305-327. doi: 10.1016/S1383-5742(99)00057-5.
198. Tanaka, S., Haruma, K., Kunihiro, M., Nagata, S., Kitadai, Y., Manabe, N., et al. (2004). Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study. Hiroshima J. Med. Sci. 53, 39-45.
199. Tang, Y., Lou, F., Wang, J., Li, Y., and Zhuang, S. (2001). Coumaroyl flavonol glycosides from the leaves of Ginkgo biloba. Phytochemistry 58, 1251-1256. doi: 10.1016/S0031-9422(01)00320-X.
200. Tasduq, S. A., Peerzada, K., Koul, S., Bhat, R., and Johri, R. K. (2005). Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin. Hepatol. Res. 31, 132-135. doi: 10.1016/j.hepres.2005.01.005.
201. Thor, H., and Orrenius, S. (1980). The mechanism of bromobenzene-induced cytotoxicity studied with isolated hepatocytes. Arch. Toxicol. 44, 31-43. doi: 10.1007/BF00303181.
202. Trackshel, G. M., and Maines, M. D. (1988). Characterization of glutathione S-transferase in rat kidney. Biochem. J. 252, 127-136. doi: 10.1042/bj2520127.
203. Tseng, S. H., Chien, T. Y., Tzeng, C. F., Lin, Y. H., Wu, C. H., and Wang, C. C. (2007). Prevention of hepatic oxidative injury by Xiao-Chen-Chi-Tang in mice. J. Ethnopharmacol. 111, 232-239. doi: 10.1016/j.jep.2006.11.030.
204. Tseng, T. H., Chu, C. Y., Huang, J. M., Shiow, S. J., and Wang, C. J. (1995). Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett. 97, 61-67. doi: 10.1016/0304-3835(95)03964-X.
205. Upadhyay, G., Gupta, S. P., Prakash, O., and Singh, M. P. (2010a). Pyrogallol-mediated toxicity and natural antioxidants: triumphs and pitfalls of preclinical findings and their translational limitations. Chem. Biol. Interact. 183, 333-340. doi: 10.1016/j.cbi.2009.11.028.
206. Upadhyay, G., Kumar, A., and Singh, M. P. (2007). Effect of silymarin on pyrogallol-and rifampicin-induced hepatotoxicity in mouse. Eur. J. Pharmacol. 565, 190-201. doi: 10.1016/j.ejphar.2007.03.004.
207. Upadhyay, G., Singh, A. K., Kumar, A., Prakash, O., and Singh, M. P. (2008). Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress. Eur. J. Pharmacol. 596, 146-152. doi: 10.1016/j.ejphar.2008.08.019.
208. Upadhyay, G., Tiwari, M. N., Prakash, O., Jyoti, A., Shanker, R., and Singh, M. P. (2010b). Involvement of multiple molecular events in pyrogallol-induced hepatotoxicity and silymarin-mediated protection: evidence from gene expression profiles. Food Chem. Toxicol. 48, 1660-1670. doi: 10.1016/j.fct.2010.03.041.
209. Urquhart, B. L., Tirona, R. G., and Kim, R. B. (2007). Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol. 47, 566-578. doi: 10.1177/0091270007299930.
210. Vajdovich, P., Szilagyi, A., and Gall, T. (1995). Evaluating of blood lipid peroxidation parameters in carbon tetrachloride (CCl4) toxicity in sheep. Acta Vet. Hung. 43, 423-429.
211. Valenzuela, A., Guerra, R., and Garrido, A. (1987). Silybin dihemisuccinate protects rat erythrocytes against phenylhydrazine-induced lipoperoxidation and hemolysis. Planta Med. 53, 402-405. doi: 10.1055/s-2006-962757.
212. Van Beek, T. A. (2002). Chemical analysis of Ginkgo biloba leaves and extracts. J. Chromatogr. 967, 21-55. doi: 10.1016/S0021-9673(02)00172-3.
213. Vessey, D. A. (1996). "Metabolism of xenobiotics by the human liver, " in Hepatology: A Textbook of Liver Disease, 3rd Edn., eds D. Zakin and T. D. Boyer (Philadelphia: WB Saunders), 257-305.
214. Wang, R., Kong, J., Wang, D., Lin-min Lien, L., and Lien, E. J. (2007). A survey of Chinese herbal ingredients with liver protection activities. Chin. Med. 2:5. doi: 10.1186/1749-8546-2-5.
215. Wang, Y., Jiang, Y., Fan, X., Tan, H., Zeng, H., Wang, Y., et al. (2015). Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathways. Toxicol. Lett. 236, 82-89. doi: 10.1016/j.toxlet.2015.05.001.
216. Waseem, M., Pandey, P., Tomar, B., Raisuddin, S., and Parvez, S. (2014). Ameliorative action of curcumin in cisplatin-mediated hepatotoxicity: an in vivo study in Wistar rats. Arch. Med. Res. 45, 462-468. doi: 10.1016/j.arcmed.2014.07.006.
217. Watanabe, C. M., Wolffram, S., Ader, P., Rimbach, G., Packer, L., Maguire, J. J., et al. (2001). The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc. Natl. Acad. Sci. U.S.A. 98, 6577-6580. doi: 10.1073/pnas.111126298.
218. Waxman, D. J. (1999). P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369, 11-23. doi: 10.1006/abbi.1999.1351.
219. Wellington, K., and Jarvis, B. (2001). Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 15, 465-489. doi: 10.2165/00063030-200115070-00005.
220. Wesnes, K. A., Ward, T., McGinty, A., and Petrini, O. (2000). The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 152, 353-361. doi: 10.1007/s002130000533.
221. Wolf, K. K., Wood, S. G., Allard, J. L., Hunt, J. A., Gorman, N., Walton-Strong, B. W., et al. (2007). Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice. Drug Metab. Dispos. 35, 1223-1231. doi: 10.1124/dmd.107.014738.
222. Woods, C. G., Vanden Heuvel, J. P., and Rusyn, I. (2007). Genomic profiling in nuclear receptor-mediated toxicity. Toxicol. Pathol. 35, 474-494. doi: 10.1080/01926230701311351.
223. Wood, G. C., and Woodcock, B. G. (1970). Effects of dietary protein deficiency on the conjugation of foreign compounds in rat liver. J. Pharm. Pharmacol. Suppl:60S+. doi: 10.1111/j.2042-7158.1970.tb08581.x.
224. Wu, S. J., Wang, J. S., Lin, C. C., and Chang, C. H. (2001). Evaluation of hepatoprotective activity of legumes. Phytomedicine 8, 213-219. doi: 10.1078/0944-7113-00033.
225. Wu, Y. G., Xia, L. L., Lin, H., Zhou, D., Qian, H., and Lin, S. T. (2007b). Prevention of early liver injury by breviscapine in streptozotocin-induced diabetic rats. Planta Med. 73, 433-438. doi: 10.1055/s-2007-967182.
226. Wu, Y., Li, L., Wen, T., and Li, Y. Q. (2007a). Protective effects of echinacoside on carbon tetrachloride-induced hepatotoxicity in rats. Toxicology 232, 50-56. doi: 10.1016/j.tox.2006.12.013.
227. Xu, J. K., Hiroshi, K., Zheng, J. J., Jiang, T., and Yao, X. S. (2006). Protective effect of tanshinones against liver injury in mice loaded with restraint stress. Yao Xue Xue Bao 41, 631-635.
228. Yamazaki, Y., Kakizaki, S., Horiguchi, N., Takagi, H., Mori, M., and Negishi, M. (2005). Role of nuclear receptor CAR in carbon tetrachloride-induced hepatotoxicity. World J. Gastroenterol. 11, 5966-5972. doi: 10.3748/wjg.v11.i38.5966.
229. Yang, L., Wang, C. Z., Ye, J. Z., and Li, H. T. (2011). Hepatoprotective effects of polyprenols from Ginkgo biloba L. leaves on CCl4-induced hepatotoxicity in rats. Fitoterapia 82, 834-840. doi: 10.1016/j.fitote.2011.04.009.
230. Yang, M., Xu, D. D., Zhang, Y., Liu, X., Hoeven, R., and Cho, W. C. (2014a). A systematic review on natural medicines for the prevention and treatment of Alzheimer's disease with meta-analyses of intervention effect of ginkgo. Am. J. Chin. Med. 42, 505-521. doi: 10.1142/S0192415X14500335.
231. Yang, Z., Zhuang, L., Lu, Y., Xu, Q., and Chen, X. (2014b). Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials. Biomed Res Int. 2014:941085. doi: 10.1155/2014/941085.
232. Yarnell, E., and Abascal, K. (2007). Interaction of herbal constituents with cytochrome P450 Enz. Alternat. Complement. Ther. 13, 239-247. doi: 10.1089/act.2007.13508.
233. Yin, F., Liu, J., Ji, X., Wang, Y., Zidichouski, J., and Zhang, J. (2011). Silibinin: a novel inhibitor of Aβ aggregation. Neurochem. Int. 58, 399-403. doi: 10.1016/j.neuint.2010.12.017.
234. Young, J. F., Dragsted, L. O., Daneshvar, B., Lauridsen, S. T., Hansen, M., and Sandström, B. (2000). The effect of grape-skin extract on oxidative status. Br. J. Nutr. 84, 505-513.
235. Young, S. C., Wang, C. J., Lin, J. J., Peng, P. L., Hsu, J. L., and Chou, F. P. (2007). Protection effect of piper betel leaf extract against carbon tetrachloride-induced liver fibrosis in rats. Arch. Toxicol. 81, 45-55. doi: 10.1007/s00204-006-0106-0.
236. Yu, C. Y., Kim, S. H., Lim, J. D., Kim, M. J., and Chung, I. M. (2003). Intraspecific relationship analysis by DNA markers and in vitro cytotoxic and antioxidant activity in Eleutherococcus senticosus. Toxicol. In Vitro 17, 229-236. doi: 10.1016/S0887-2333(03)00008-0.
237. Zhang, Z., Gao, L., Cheng, Y., Jiang, J., Chen, Y., Jiang, H., et al. (2014). Resveratrol, a natural antioxidant, has a protective effect on liver injury induced by inorganic arsenic exposure. Biomed. Res. Int. 2014:617202. doi: 10.1155/2014/617202.
238. Zhong, M. M., Chen, F. H., Yuan, L. P., Wang, X. H., Wu, F. R., Yuan, F. L., et al. (2007). Protective effect of total flavonoids from Bidens bipinnata L. against carbon tetrachloride-induced liver injury in mice. J. Pharm. Pharmacol. 59, 1017-1025. doi: 10.1211/jpp.59.7.0015.
239. Zi, X., and Agarwal, R. (1999). Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc. Natl. Acad. Sci. U.S.A. 96, 7490-7495. doi: 10.1073/pnas.96.13.7490.
240. Zi, X., Grasso, A. W., Kung, H.-J., and Agarwal, R. (1998). A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclindependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Cancer Res. 58, 1920-1929.
241. Zi, X., Mukhtar, H., and Agarwal, R. (1997). Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of m RNA expression of an endogenous tumor promoter TNF-a. Biochem. Biophys. Res. Commun. 239, 334-339. doi: 10.1006/bbrc.1997.7375.
242. Zou, Y., Yang, Y., Li, J., Li, W., and Wu, Q. (2006). Prevention of hepatic injury by a traditional Chinese formulation, BJ-JN, in mice treated with Bacille-Calmette-Guérin and lipopolysaccharide. J. Ethnopharmacol. 107, 442-448. doi: 10.1016/j.jep.2006.04.006.